Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Wedemeyer H, Schuller E, Schlaphoff V, Stauber RE, Wiegand J, Schiefke I, Firbas C, Jilma B, Thursz M, Zeuzem S, Hofmann WP, Hinrichsen H, Tauber E, Manns MP, Klade CS.
Wedemeyer H, et al. Among authors: klade cs.
Vaccine. 2009 Aug 13;27(37):5142-51. doi: 10.1016/j.vaccine.2009.06.027. Epub 2009 Jun 24.
Vaccine. 2009.
PMID: 19559112
Clinical Trial.